LUMATEPERONE | LUMATEPERONE | ATC N05AD10
NERVOUS SYSTEM ANTIPSYCHOTIC INDICATED FOR THE TREATMENT OF SCHIZOPHRENIA IN ADULTS ACTIVITY COULD BE ANTAGONISTIC ACTIVITY AT CENTRAL SEROTONIN 5-HT2A RECEPTORS (KI = 0.54 NM) AND DOPAMINE D2 RECEPTORS (KI = 32 NM) | ORAL | Tmax 1.5 HOUR F 4.4 PERCENT VD 266.5 LITER (65 KILOGRAM) PPB 97.4 PERCENT Cl 27.9 LITER / HOUR HT 18 HOUR | 5-HT2A RECEPTORS DOPAMINE D2 RECEPTORS | 5-hydroxytryptamine receptor 2A P28223 5HT2A_HUMAN | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |